Liu, Jianying
Liu, Yang
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Zou, Jing
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Swanson, Kena A. http://orcid.org/0000-0002-3389-8414
Cai, Hui
Cutler, Mark
Cooper, David
Muik, Alexander http://orcid.org/0000-0003-4561-2273
Jansen, Kathrin U.
Sahin, Ugur
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Dormitzer, Philip R. http://orcid.org/0000-0003-0671-6360
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Article History
Received: 19 May 2021
Accepted: 4 June 2021
First Online: 10 June 2021
Competing interests
: X.X. and P.-Y.S. have filed a patent on the reverse genetic system of SARS-CoV-2. K.A.S., H.C., M.C., D.C., K.U.J., and P.R.D. are employees of Pfizer and may hold stock options. A.M. and U.S. are employees of BioNTech and may hold stock options. Y.L., H.X., J.Z., X.X. and P.-Y.S. received compensation from Pfizer to perform the project.
Free to read: This content has been made available to all.